# Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers

> **NCT04186559** · PHASE2 · UNKNOWN · sponsor: **Silk Road Therapies, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Behcet Syndrome
- Behcet Disease

## Interventions

- **DRUG:** Topical Pentoxifylline Gel (Vehicle +PTX)
- **DRUG:** Topical Placebo Gel (Vehicle)

## Key facts

- **NCT ID:** NCT04186559
- **Lead sponsor:** Silk Road Therapies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02
- **Primary completion:** 2024-11
- **Final completion:** 2024-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04186559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04186559, "Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04186559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
